PLoS ONE (Jan 2011)

Uncovering genomic causes of co-morbidity in epilepsy: gene-driven phenotypic characterization of rare microdeletions.

  • Dalia Kasperavičiūtė,
  • Claudia B Catarino,
  • Krishna Chinthapalli,
  • Lisa M S Clayton,
  • Maria Thom,
  • Lillian Martinian,
  • Hannah Cohen,
  • Shazia Adalat,
  • Detlef Bockenhauer,
  • Simon A Pope,
  • Nicholas Lench,
  • Martin Koltzenburg,
  • John S Duncan,
  • Peter Hammond,
  • Raoul C M Hennekam,
  • John M Land,
  • Sanjay M Sisodiya

DOI
https://doi.org/10.1371/journal.pone.0023182
Journal volume & issue
Vol. 6, no. 8
p. e23182

Abstract

Read online

Patients with epilepsy often suffer from other important conditions. The existence of such co-morbidities is frequently not recognized and their relationship with epilepsy usually remains unexplained.We describe three patients with common, sporadic, non-syndromic epilepsies in whom large genomic microdeletions were found during a study of genetic susceptibility to epilepsy. We performed detailed gene-driven clinical investigations in each patient. Disruption of the function of genes in the deleted regions can explain co-morbidities in these patients.Co-morbidities in patients with epilepsy can be part of a genomic abnormality even in the absence of (known) congenital malformations or intellectual disabilities. Gene-driven phenotype examination can also reveal clinically significant unsuspected condition.